RTW INVESTMENTS LP 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:28 am Purchase | 2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW INVESTMENTS LP | 3,152,341 9.500% | 604,216 (+23.71%) | Filing |
| 2023-02-14 10:09 am Purchase | 2022-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW INVESTMENTS LP | 2,548,125 9.600% | 534,524 (+26.55%) | Filing |
| 2022-02-14 08:18 am Sale | 2021-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW INVESTMENTS LP | 2,013,601 9.700% | -450,000 (-18.27%) | Filing |
| 2021-02-12 09:42 am Unchanged | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW INVESTMENTS LP | 2,463,601 12.130% | 0 (Unchanged) | Filing |
| 2020-10-26 2:16 pm Purchase | 2020-10-16 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW INVESTMENTS LP | 2,463,601 12.790% | 2,463,601 (New Position) | Filing |